• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术与辅助治疗之间的时间间隔与口腔癌患者生存的关系。

Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer.

机构信息

1 Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California, USA.

2 Department of Radiation Oncology, Stanford Cancer Center, Stanford University, Stanford, California, USA.

出版信息

Otolaryngol Head Neck Surg. 2018 Jun;158(6):1051-1056. doi: 10.1177/0194599817751679. Epub 2018 Jan 9.

DOI:10.1177/0194599817751679
PMID:29313448
Abstract

Objective The National Cancer Center Network recommends starting radiation therapy within 6 weeks after surgery for oral cavity squamous cell carcinoma (OCSCC), but there is limited evidence of the importance of the total time from surgery to completion of radiation therapy (package time). We set out to determine if there was an association between package time and survival in OCSCC and to evaluate the impact of treatment location on outcomes. Study Design Retrospective cohort study. Setting Tertiary academic medical center. Subjects and Methods We reviewed the records of patients with OCSCC who completed postoperative radiation therapy at an academic medical center from 2008 to 2016. The primary endpoints were overall survival and recurrence-free survival. Statistical analysis included χ tests and Cox proportional hazards regressions. Results We identified 132 patients with an average package time of 12.6 weeks. On multivariate analysis, package time >11 weeks was independently associated with decreased overall survival (hazard ratio, 6.68; 95% CI, 1.42-31.44) and recurrence-free survival (hazard ratio, 2.94; 95% CI, 1.20-7.18). Patients who received radiation therapy at outside facilities were more likely to have treatment delays (90.2% vs 62.9%, P = .001). Conclusions Prolonged package times are associated with decreased overall and recurrence-free survival among patients with OCSCC. Patients who received radiation therapy at outside facilities are more likely to have prolonged package times.

摘要

目的

美国国家癌症中心网络建议口腔鳞状细胞癌(OCSCC)患者在手术后 6 周内开始放射治疗,但关于手术到放射治疗完成的总时间(治疗套餐时间)的重要性的证据有限。我们旨在确定 OCSCC 患者的治疗套餐时间与生存之间是否存在关联,并评估治疗地点对结果的影响。

研究设计

回顾性队列研究。

设置

三级学术医疗中心。

受试者和方法

我们回顾了 2008 年至 2016 年在学术医疗中心完成术后放射治疗的 OCSCC 患者的记录。主要终点是总生存率和无复发生存率。统计分析包括 χ 检验和 Cox 比例风险回归。

结果

我们确定了 132 例平均治疗套餐时间为 12.6 周的患者。多变量分析显示,治疗套餐时间>11 周与总生存率(风险比,6.68;95%置信区间,1.42-31.44)和无复发生存率(风险比,2.94;95%置信区间,1.20-7.18)降低独立相关。在外部设施接受放射治疗的患者更有可能出现治疗延迟(90.2%比 62.9%,P =.001)。

结论

OCSCC 患者的治疗套餐时间延长与总生存率和无复发生存率降低有关。在外部设施接受放射治疗的患者更有可能出现治疗套餐时间延长。

相似文献

1
Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer.手术与辅助治疗之间的时间间隔与口腔癌患者生存的关系。
Otolaryngol Head Neck Surg. 2018 Jun;158(6):1051-1056. doi: 10.1177/0194599817751679. Epub 2018 Jan 9.
2
Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis.学术中心口腔癌辅助放疗的疗效改善:配对分析
Laryngoscope. 2014 Jul;124(7):1603-8. doi: 10.1002/lary.24552. Epub 2014 Feb 6.
3
Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.口腔鳞状细胞癌术后辅助放疗和挽救性放疗的长期预后
Laryngoscope. 2018 Nov;128(11):2539-2545. doi: 10.1002/lary.27191. Epub 2018 Apr 10.
4
Estimating Survival After Salvage Surgery for Recurrent Oral Cavity Cancer.复发性口腔癌挽救性手术后的生存情况评估。
JAMA Otolaryngol Head Neck Surg. 2017 Jul 1;143(7):685-690. doi: 10.1001/jamaoto.2017.0001.
5
Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.放疗后与散发性口腔鳞状细胞癌的临床结局、病理特征和免疫相关特征比较。
JAMA Netw Open. 2023 Jul 3;6(7):e2323890. doi: 10.1001/jamanetworkopen.2023.23890.
6
Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion.口腔舌癌 II 期:基于侵袭深度的辅助放疗对生存的影响。
Otolaryngol Head Neck Surg. 2019 Jan;160(1):77-84. doi: 10.1177/0194599818779907. Epub 2018 Jun 26.
7
Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.诱导选择化疗与原发手术治疗晚期口腔癌患者的疗效比较。
JAMA Otolaryngol Head Neck Surg. 2014 Feb;140(2):134-42. doi: 10.1001/jamaoto.2013.5892.
8
Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study.口腔鳞状细胞癌患者生存率的提高:一项国际合作研究。
Cancer. 2013 Dec 15;119(24):4242-8. doi: 10.1002/cncr.28357. Epub 2013 Sep 20.
9
Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.对比 cT1-2N0M0 口腔鳞癌初始手术与剂量≥6600 cGy 的根治性放疗的临床结局:一项全国性队列研究。
Cancer Med. 2024 May;13(10):e7127. doi: 10.1002/cam4.7127.
10
cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma.与 cN0pN0 患者相比,口腔鳞状细胞癌切除术后的 cN+pN0 疾病并不预示预后较差。
Cancer Med. 2021 Oct;10(20):6947-6958. doi: 10.1002/cam4.4187. Epub 2021 Sep 23.

引用本文的文献

1
Treatment package time in high-risk oral cavity squamous cell carcinoma: where are we failing and at what cost?高危口腔鳞状细胞癌的治疗套餐时间:我们在哪里失败了,代价是什么?
Rep Pract Oncol Radiother. 2025 Jun 7;30(2):155-163. doi: 10.5603/rpor.105253. eCollection 2025.
2
Treatment package time (TPT) and surgery to post-operative radiotherapy (S-PORT) interval in head and neck cancers: A systematic review and meta-analysis.头颈部癌症的治疗套餐时间(TPT)及手术至术后放疗(S-PORT)间隔:一项系统评价与荟萃分析
Eur Arch Otorhinolaryngol. 2025 Jun 21. doi: 10.1007/s00405-025-09517-3.
3
Impact of Postoperative Radiation Therapy Delay and Treatment Facility Location on Survival in Head and Neck Cancer Patients.
术后放疗延迟及治疗机构地点对头颈部癌患者生存的影响
Head Neck. 2025 Jul;47(7):1807-1815. doi: 10.1002/hed.28092. Epub 2025 Jan 31.
4
Risk Classification of Oral Cancer Surgical Margins: Margin to Depth of Invasion Ratio Analysis.口腔癌手术切缘的风险分类:切缘与浸润深度比值分析
Ann Surg Oncol. 2025 Apr 23. doi: 10.1245/s10434-025-17286-w.
5
Randomized Trial of Enhanced Versus Standard Navigation to Promote Timely Initiation of Adjuvant Radiotherapy for Head and Neck Cancer.增强型导航与标准导航促进头颈癌辅助放疗及时启动的随机试验
JCO Oncol Pract. 2025 Jan 6:OP2400901. doi: 10.1200/OP-24-00901.
6
Delayed Postoperative Radiotherapy in Head & Neck Cancers-A Systematic Review and Meta-Analysis.头颈部癌症术后延迟放疗的系统评价与Meta分析
Laryngoscope. 2025 May;135(5):1563-1570. doi: 10.1002/lary.31990. Epub 2025 Jan 2.
7
Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes.外科医生与放射肿瘤学医生组合对口腔癌治疗结果的影响
Ann Surg Oncol. 2025 Feb;32(2):1270-1279. doi: 10.1245/s10434-024-16385-4. Epub 2024 Oct 28.
8
Missed Adjuvant Therapy in Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma.人乳头瘤病毒阳性口咽鳞状细胞癌辅助治疗的遗漏
Laryngoscope. 2025 Feb;135(2):729-740. doi: 10.1002/lary.31823. Epub 2024 Oct 8.
9
Choice of Adjuvant Radiotherapy Facility in Sinonasal Squamous Cell Carcinoma.鼻腔鼻窦鳞状细胞癌辅助放疗设备的选择
Laryngoscope. 2025 Feb;135(2):705-715. doi: 10.1002/lary.31794. Epub 2024 Sep 24.
10
The impact of interval between surgery and postoperative radiotherapy in major salivary gland carcinoma.手术与术后放疗间隔时间对大唾液腺癌的影响。
J Natl Cancer Cent. 2022 Jun 19;2(3):188-194. doi: 10.1016/j.jncc.2022.06.001. eCollection 2022 Sep.